Switch to:
Hi-Tech Pharmacal Co., Inc. (NAS:HITK)
EV/EBIT
0.00 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Hi-Tech Pharmacal Co., Inc.'s enterprise value is $0.0 Mil. Hi-Tech Pharmacal Co., Inc.'s earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2014 was $13.0 Mil. Therefore, Hi-Tech Pharmacal Co., Inc.'s EV/EBIT ratio for today is 0.00.

HITK' s 10-Year EV/EBIT Range
Min: 0   Max: 0
Current: 0

HITK's EV/EBITis ranked lower than
181% of the 491 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 23.81 vs. HITK: 0.00 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Hi-Tech Pharmacal Co., Inc.'s enterprise value for the quarter that ended in Jan. 2014 was $528.7 Mil. Hi-Tech Pharmacal Co., Inc.'s earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2014 was $13.0 Mil. Hi-Tech Pharmacal Co., Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jan. 2014 was 2.47%.


Definition

Hi-Tech Pharmacal Co., Inc.'s EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=0.000/13.048
=0.00

Hi-Tech Pharmacal Co., Inc.'s current Enterprise Value is $0.0 Mil.
Hi-Tech Pharmacal Co., Inc.'s Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2014 was -8.173 (Apr. 2013 ) + 6.997 (Jul. 2013 ) + 1.844 (Oct. 2013 ) + 12.38 (Jan. 2014 ) = $13.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Hi-Tech Pharmacal Co., Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jan. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Jan. 2014 )=EBIT (TTM)/Enterprise Value (Q: Jan. 2014 )
=13.048/528.7102
=2.47 %

Hi-Tech Pharmacal Co., Inc.'s Enterprise Value for the quarter that ended in Jan. 2014 was $528.7 Mil.
Hi-Tech Pharmacal Co., Inc.'s Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2014 was -8.173 (Apr. 2013 ) + 6.997 (Jul. 2013 ) + 1.844 (Oct. 2013 ) + 12.38 (Jan. 2014 ) = $13.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Hi-Tech Pharmacal Co., Inc. Annual Data

Apr04Apr05Apr06Apr07Apr08Apr09Apr10Apr11Apr12Apr13
ev2ebit 13.0511.8017.89-21.65-11.886.196.014.804.979.34

Hi-Tech Pharmacal Co., Inc. Quarterly Data

Oct11Jan12Apr12Jul12Oct12Jan13Apr13Jul13Oct13Jan14
ev2ebit 5.195.934.976.396.469.519.3410.6314.3313.96
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK